Accord Healthcare, Inc. 2023-03-08 Health serious FDA
Health · FDA · Recall #FDA-D-0378-2023
BusPIRone Hydrochloride Tablets USP, 10 mg 500-count bottle, Rx Only, Manufactured for:… Recall
Issued March 8, 2023 · Accord Healthcare, Inc.
In March 2023, Accord Healthcare, Inc. recalled the BusPIRone Hydrochloride Tablets USP, 10 mg 500-count bottle, Rx Only, Manufactured for:…, a serious health recall reported by the FDA. Affected owners are eligible for a voluntary. Here is what the hazard is and exactly what to do about it.
Compiled by Maya Ellison, RecallCheckr
What this means for you
CGMP Deviations: recalling drug products following an FDA inspection.
What you should do
- 1 Stop using BusPIRone Hydrochloride Tablets USP, 10 mg 500-count bottle, Rx Only, Manufactured for:… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Accord Healthcare, Inc. to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Accord Healthcare, Inc.
- Category
- Health
- Recall date
- March 8, 2023
- Units affected
- Not reported
- Sold at
- United States including Puerto Rico and Canada
- Recall number
- FDA-D-0378-2023
- Made in
- United States
- Issuing agency
- FDA
In context
- Accord Healthcare, Inc. has 31 recalls in our database, including 1 rated Critical.
- We're tracking 3,576 Health recalls in our database.
- This is the 903rd Health recall we've logged in 2023.